AbbVie Presents Extended Follow-Up Data for Fixed Duration Treatment VENCLEXTA/VENCLYXTO (venetoclax) in Chronic Lymphocytic Leukemia (CLL)

Mount Carmel Register

Dec 5, 2020

AbbVie Presents Extended Follow-Up Data for Fixed Duration Treatment VENCLEXTA/VENCLYXTO (venetoclax) in Chronic Lymphocytic Leukemia (CLL) |!| Mount Carmel